Literature DB >> 16103635

Angioimmunoblastic T cell lymphoma with an unusual proliferation of Epstein-Barr virus-associated large B cells arising in a patient with progressive systemic sclerosis.

Hidesuke Yamamoto1, Hiroshi Miwa, Yoshiro Kato, Shigeo Nakamura, Kazuo Hara, Masakazu Nitta.   

Abstract

We report an unusual case of angioimmunoblastic T cell lymphoma arising in the setting of 5 years of immunosuppressive treatment for progressive systemic sclerosis. The lymph node lesion was accompanied by large blastic B cells with an association of Epstein-Barr virus. Southern blot study demonstrated the clonal rearrangement of T cell receptor beta-chain gene, but not of immunoglobulin heavy chain gene. Phenotypical examination of the lymph node also revealed the predominance of CD4+ T cells in addition to the proliferation of follicular dendritic cells, but no light chain restriction in large B cell components. In the clinical and laboratory aspects, neutrophilia (15.8 x 10(9)/l) and plasmacytosis (40%) in bone marrow were noted, which were considered to be closely related to elevated serum granulocyte colony-stimulating factor, interleukin (IL)-4 and IL-6. Based on the combined data described here, our preferred diagnosis was angioimmunoblastic T cell lymphoma with Epstein-Barr virus-associated B cell lymphoproliferative disorder, the pathogenesis of which was suggested to be closely associated with immunosuppressive treatment for progressive systemic sclerosis. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16103635     DOI: 10.1159/000086585

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

1.  Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Authors:  Claudio Tripodo; Giorgia Gri; Pier Paolo Piccaluga; Barbara Frossi; Carla Guarnotta; Silvia Piconese; Giovanni Franco; Valeria Vetri; Carlo Ennio Pucillo; Ada Maria Florena; Mario Paolo Colombo; Stefano Aldo Pileri
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 2.  Fresh Insights into Disease Etiology and the Role of Microbial Pathogens.

Authors:  Antonella Farina; G Alessandra Farina
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 3.  Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.

Authors:  Serena Vettori; Stefania Staibano; Massimo Mascolo; Gennaro Ilardi; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2009-10-07       Impact factor: 2.980

4.  Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.

Authors:  Tommi Pätilä; Shigeru Miyagawa; Yukiko Imanishi; Satsuki Fukushima; Antti Siltanen; Eero Mervaala; Esko Kankuri; Ari Harjula; Yoshiki Sawa
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

5.  Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.

Authors:  M Colaci; D Giuggioli; C Vacchi; C Ferri
Journal:  Case Rep Rheumatol       Date:  2017-05-04

Review 6.  Upcoming treatments for morphea.

Authors:  Dan Wenzel; Nazgol-Sadat Haddadi; Khashayar Afshari; Jillian M Richmond; Mehdi Rashighi
Journal:  Immun Inflamm Dis       Date:  2021-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.